Mr. Speaker, the number one issue that my constituents have asked me to address is the price of healthcare and, especially, the cost of prescription drugs. It is long past time for commonsense legislation to end the ban on price negotiation for drugs for our Nation's Medicare patients. This one action will hold Big Pharma accountable and encourage more competition. That is why the special interests have opposed H.R. 3, because it forces them to lower their prices for U.S. patients. We can use the money saved to lower premiums, cap out-of-pocket costs for our Nation's seniors, and invest in the National Institutes of Health's lifesaving research and innovation. These are decisions that impact real people. Take my constituent from Rosemount. He has Crohn's disease and takes a medication called Canasa. When he started taking the drug, it was $100 for a 30-day supply. Over the past 10 years, that has skyrocketed to $1,500 a month. In Canada, that same drug costs $75 a month. It is time to stop talking and take action. ____________________
Share & report
More from Angie Craig
Mr. Chairman, I support parents' rights, and I am proud to live in the State of Minnesota where parents have a right to remove their child from a class assignment if they are not comfortable with the subject matter. That is State law today…
The work that you and the Biden Administration have done following the passage of the Inflation Reduction Act to invest in innovative strategies to cut climate pollution, create good-paying jobs for Minnesotans, and accelerate our…
Clearly that rescheduling, scheduling at it as a class I one drug, is not the silver bullet that some politicians would have us think that it is.
Madam Chair, like many of my colleagues on both sides of the aisle here today, I believe we need an all-of-the-above energy approach in this country. As a Member of Congress representing a district that is 65 percent covered in corn and…





